Vial
About:
Scalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics.
Website: https://vial.com
Twitter/X: vialtrials
Top Investors: General Catalyst, BoxGroup, Buckley Ventures, Gordon Wintrob, Josh Buckley
Description:
Vial is a hyper scalable biotech — advancing programs into the clinic powered by dramatically lower cost trials and computationally designed therapeutics.
Total Funding Amount:
$101M
Estimated Revenue Range:
$100M to $500M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2020-01-01
Contact Email:
hello(AT)vialtrials.com
Founders:
Andrew Brackin, Simon Burns
Number of Employees:
101-250
Last Funding Date:
2022-11-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai